Upstream Bio (UPB) EPS (Weighted Average and Diluted) (2023 - 2025)
Historic EPS (Weighted Average and Diluted) for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to -$0.63.
- Upstream Bio's EPS (Weighted Average and Diluted) rose 9094.83% to -$0.63 in Q3 2025 from the same period last year, while for Sep 2025 it was $10.69, marking a year-over-year increase of 14609.75%. This contributed to the annual value of -$5.58 for FY2024, which is 5688.43% up from last year.
- According to the latest figures from Q3 2025, Upstream Bio's EPS (Weighted Average and Diluted) is -$0.63, which was up 9094.83% from -$0.74 recorded in Q2 2025.
- Over the past 5 years, Upstream Bio's EPS (Weighted Average and Diluted) peaked at -$0.51 during Q1 2025, and registered a low of -$6.96 during Q3 2024.
- Its 3-year average for EPS (Weighted Average and Diluted) is -$3.2, with a median of -$2.11 in 2023.
- Per our database at Business Quant, Upstream Bio's EPS (Weighted Average and Diluted) tumbled by 22985.78% in 2024 and then surged by 9094.83% in 2025.
- Upstream Bio's EPS (Weighted Average and Diluted) (Quarter) stood at -$5.05 in 2023, then skyrocketed by 68.46% to -$1.59 in 2024, then soared by 60.44% to -$0.63 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.63 for Q3 2025, versus -$0.74 for Q2 2025 and -$0.51 for Q1 2025.